A consistent topic of today’s political debate is the cost of health care and how to lower these costs, including drug prices. The debate often focuses on patients with complex health needs, who also face higher bills for their care. What I continue to find puzzling is, despite the narrative of lowering prices to help patients, the patient community is rarely consulted or engaged with while these policies are being developed.
(248) 520-2329
